11 Amendments of Aldo PATRICIELLO related to 2020/2071(INI)
Amendment 49 #
Motion for a resolution
Recital A b (new)
Recital A b (new)
Ab. whereas uncoordinated initiatives at national level, such as stockpiling and penalties, are not the right solution and could lead to an increased risk of medicines shortage;
Amendment 102 #
Motion for a resolution
Recital C a (new)
Recital C a (new)
Ca. whereas existing manufacturing capabilities are numerous in the EU and it is crucial to secure them through sustainable economic, regulatory and industrial policies;
Amendment 189 #
Motion for a resolution
Recital J a (new)
Recital J a (new)
Ja. whereas an efficient strategy should cover measures to mitigate medicines shortage, but also to prevent them from happening, looking at the multiple root causes of shortages ;
Amendment 210 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Points out the necessity to develop a single pan-European harmonised reporting and notification system for medicines shortage to ensure coordination within the single market, and a close dialogue with industry and other relevant actors of the supply chain; considers that such a system should focus on a pan-European critical list of products, covering both Centralised and National Marketing Authorisations; in this context, a single pan-European Definition for Critical List of Medicines should be defined in coordination with relevant stakeholders;
Amendment 362 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Urges the Commission and Member States to put the right economic framework in place to secure and modernise existing manufacturing capabilities of medicines, technology and APIs in Europe, for example by rewarding investments in medicines quality and security of supply;
Amendment 420 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Calls on the Commission and the Member States to create one or more European non-profit pharmaceutical undertakings which operate in the public interest to manufacture priority medicines of strategic importance for health care; sStresses the key contribution that can be made by new technologies and artificial intelligence in enabling European laboratory researchers to form networks and share their objectives and findings;
Amendment 458 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Stresses the importance of research and innovation, also in the off patent segment, and calls for the establishment of a genuine European network, given that the price of relocation must not be a deterioration in the quality of medical research;
Amendment 528 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Calls on the Commission to develop European health strategies on the basis of a common basket of drugs for the treatment of cancer and infections whose prices are harmonised, in a bid to counter recurrent shortages and ensure that patients have access to treatment, while making sure to avoid any further consolidation of the supply chain;
Amendment 608 #
Motion for a resolution
Paragraph 17
Paragraph 17
Amendment 695 #
Motion for a resolution
Paragraph 20
Paragraph 20
20. Calls for an electronic information notice to be drawn up in all the Union languages for every medicine on the EU marketthe replacement the paper leaflet with the implementation of electronic product information leaflet in all the languages, in order to facilitate sales ofmoving medicines between Member States; recommends the provision of more comprehensive information on the origin of medicineswithin the Single Market to prevent a shortage;
Amendment 720 #
Motion for a resolution
Paragraph 21 a (new)
Paragraph 21 a (new)
21a. Calls on the Commission, EMA and national regulatory authorities, capitalizing on all pragmatic efforts made during the COVID-19 crisis, to continue to allow regulatory flexibilities for Marketing Authorisations Holders, for example covering procedures for changes in suppliers of APIs, the designation of new manufacturing sites, faster import authorisations, leading to better mitigation of medicines shortage ;